Viewpoints

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Research from ASCO indicates treatment of locally advanced head and neck cancer should be carefully considered in patients older than 70.

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Feature Articles

Immunotherapies Shine at ASCO Annual Meeting

Immunotherapies Shine at ASCO Annual Meeting

FDA-approved immunotherapies are showing efficacy in different cancer types and combination therapies with new biologics are displaying increased efficacy.

Head and Neck Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs